Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Edge Therapeut Cm S (EDGE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,532
  • Shares Outstanding, K 31,328
  • Annual Sales, $ 0 K
  • Annual Income, $ -50,860 K
  • 36-Month Beta 3.73
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.42
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.89
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/07/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.37 +10.81%
on 02/12/19
0.51 -19.61%
on 02/04/19
+0.02 (+5.13%)
since 01/15/19
3-Month
0.28 +46.43%
on 12/28/18
0.85 -51.76%
on 11/26/18
-0.30 (-42.42%)
since 11/15/18
52-Week
0.28 +46.43%
on 12/28/18
17.77 -97.69%
on 03/12/18
-13.49 (-97.05%)
since 02/15/18

Most Recent Stories

More News
Edge Technology Group Announces Continued Organic Growth, Adding 63 New Clients in 2018

Edge Technology Group, a privately-owned fully-managed IT service provider and trusted technology advisor for leading financial firms worldwide, added 63 new clients in 2018. This brings...

EDGE : 0.41 (+2.50%)
Lifshitz & Miller LLP Announces Investigation of Bluebird Bio, Inc., Cavco Industries, Inc., Edge Therapeutics, Inc., Inuvo, Inc., Lumentum Holdings, Inc., National Commerce Corporation, and Nobilis Health Corp.

Bluebird Bio, Inc. (BLUE)

CVCO : 140.12 (+0.41%)
INUV : 1.24 (-4.62%)
BLUE : 137.03 (+2.04%)
NCOM : 43.25 (+0.56%)
HLTH : 0.40 (-2.44%)
EDGE : 0.41 (+2.50%)
LITE : 46.65 (+1.97%)
EDGE THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Edge Therapeutics, Inc. - EDGE

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Edge Therapeutics, Inc. ("EDGE")...

EDGE : 0.41 (+2.50%)
Edison issues update on NetScientific (NSCI)

In late November 2018, NetScientific (AIM: NSCI) announced that its portfolio company PDS Biotechnology and Edge Therapeutics (NASDAQ: EDGE) will merge. The new entity will trade on the NASDAQ and PDS's...

EDGE : 0.41 (+2.50%)
EDGE THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Edge Therapeutics, Inc. - EDGE

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Edge Therapeutics, Inc. ("EDGE") (NasdaqGS: EDGE)...

EDGE : 0.41 (+2.50%)
Today's Research Reports on Trending Tickers: Zafgen and Edge Therapeutics

NEW YORK, NY / ACCESSWIRE / November 27, 2018 / Zafgen was one of the big decliners in the biotech arena after the FDA put a clinical hold on its Investigational New Drug Application. Shares of Edge Therapeutics...

ZFGN : 4.47 (+0.22%)
EDGE : 0.41 (+2.50%)
EDGE THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger

Rigrodsky & Long, P.A.:

EDGE : 0.41 (+2.50%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Edge Therapeutics, Inc. to PDS Biotechnology Corporation is Fair to Shareholders

The following statement is being issued by Levi & Korsinsky, LLP:

EDGE : 0.41 (+2.50%)
Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy Company

-Merger would create publicly-traded immuno-oncology biotechnology company developing novel products for treating early- and late-stage cancer-

EDGE : 0.41 (+2.50%)
Edge Therapeutics: 3Q Earnings Snapshot

BERKELEY HEIGHTS, N.J. (AP) _ Edge Therapeutics Inc. (EDGE) on Thursday reported a loss of $4.3 million in its third quarter.

EDGE : 0.41 (+2.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade EDGE with:

Business Summary

Edge Therapeutics, Inc. is a biotechnology company which discovers, develops and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product candidate which are in preclinical trial EG-1962, a polymer-based microparticle used for the treatment of aneurysmal...

See More

Key Turning Points

2nd Resistance Point 0.43
1st Resistance Point 0.42
Last Price 0.41
1st Support Level 0.39
2nd Support Level 0.37

See More

52-Week High 17.77
Fibonacci 61.8% 11.09
Fibonacci 50% 9.03
Fibonacci 38.2% 6.96
Last Price 0.41
52-Week Low 0.28

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar